If you need more lookups,
subscriptions start at $34 USD/month.
Mark Nedelman Location
Naples, FL, US
Mark Nedelman Work
2025 -now Founder, President and CEO @
2025 -now Managing Director @ ImmunePropulsion
2022 -now Board Trustee @
2017 -now Consultant @
2016 -2023 CEO @ Biomedical Research Models, Inc. dba Biomere
2010 -2018 President and CEO @
2008 -2017 Pharm and Tox consultant @
2006 -2008 Sr. Director of Business Development @ SelectX Pharmaceuticals
1996 -2005 General Manager @
1987 -1995 Assoc Director, Head - Preclinical Pharmacology @ Centocor
1983 -1987 Nuclear Medicine Research @
Mark Nedelman Education
Northeastern University
MBA (College of Business Administration)
2006-2007
University of Cincinnati
MS (Biology)
1981-1983
University of Cincinnati
B.S. (Biology)
1978-1980
Mark Nedelman Skills
Biotechnology
CRO
Drug Discovery
Clinical Development
Lifesciences
Oncology
Infectious Diseases
FDA
Translational Research
Molecular Biology
Hardware Diagnostics
Biopharmaceuticals
Toxicology
Technology Transfer
Biomarkers
Immunology
Life Sciences
Pharmaceutical Industry
Drug Development
Pharmacology
U.S. Food and Drug Administration (FDA)
CRO Management
Engineering
Business Strategy
Business Analysis
u.s. Food and Drug Administration Fda
Team Building
Sales
Strategic Planning
Nuclear Medicine
u.s. Food and Drug Administration
Mark Nedelman Summary
Mark Nedelman, based in Naples, FL, US, is currently a Founder, President and CEO at ANEWCRO, LLC.. Mark Nedelman brings experience from previous roles at ImmunePropulsion, XenoTherapeutics, CeleCor Therapeutics and Biomedical Research Models, Inc. dba Biomere. Mark Nedelman holds a 2006 - 2007 MBA in College of Business Administration @ Northeastern University. With a robust skill set that includes Biotechnology, CRO, Drug Discovery, Clinical Development, Lifesciences and more. Mark Nedelman has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Mark Nedelman?
Find contact details for 700 million professionals.